share_log

HC Wainwright & Co. Reiterates Buy on Anebulo Pharmaceuticals, Maintains $6 Price Target

Benzinga ·  Sep 25, 2023 06:10

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Anebulo Pharmaceuticals (NASDAQ:ANEB) with a Buy and maintains $6 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment